Deciphera Pharmaceuticals
Ulrike Beckert is a seasoned professional in market access with extensive experience in the pharmaceutical industry. Currently serving as Senior Director and Head of Market Access International at Deciphera Pharmaceuticals since December 2021, Ulrike has held various roles including Director Market Access International and Director Market Access DACH. Prior experience includes a tenure at Sobi - Swedish Orphan Biovitrum AB (publ) as Senior Patient Access Manager DACH, focusing on Pricing & Reimbursement for Orphan Drugs. Ulrike’s background also encompasses strategic consulting at Xcenda and project management roles in market access and pharmaceutical development. With a PharmD from Technische Universität Braunschweig, Ulrike has a solid foundation in pharmacology and has contributed to academia as a Research Scientist and Teaching Fellow.
This person is not in any teams
This person is not in any offices
Deciphera Pharmaceuticals
2 followers
Deciphera is a clinical-stage company tackling mechanisms of drug resistance that limit the rate and/or durability of response to existing cancer therapies.